Post-streptococcal Autoimmunity and Its Relevance to Epstein–Barr virus as the Potential Cause of Multiple Sclerosis - Top-Institutions - MDSpire

Post-streptococcal Autoimmunity and Its Relevance to Epstein–Barr virus as the Potential Cause of Multiple Sclerosis

  • By

  • Gavin Giovannoni

  • Olivia Payne

  • Ester Valero-Hernández

  • Angray S Kang

  • Bavneet Kaur Singh

  • David Baker

  • Kathryn Harris

  • Teresa Cutino-Moguel

  • Louisa K James

  • Benjamin Michael Bloom

  • February 12, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Immunology
    • Infectious Diseases

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Immunology
    • Virology

  • #3

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Immunology
    • Infectious Diseases

  • #4

    National Institute of Neurological Disorders and Stroke (NINDS), NIH
    National Institute of Neurological Disorders and Stroke (NINDS), NIH

    Bethesda, MD

    Key Differentiators

    • Neurology
    • Immunology
    • Virology

  • #5

    University of Cambridge
    University of Cambridge

    Cambridge, UK

    Key Differentiators

    • Neurology
    • Immunology
    • Virology

Original Source(s)

Post-streptococcal Autoimmunity and Its Relevance to Epstein–Barr virus as the Potential Cause of Multiple Sclerosis

  • by Gavin Giovannoni, Olivia Payne, Ester Valero-Hernández, Angray S Kang, Bavneet Kaur Singh, David Baker, Kathryn Harris, Teresa Cutino-Moguel, Louisa K James, Benjamin Michael Bloom

  • February 12, 2026

Related Content

Live Attenuated Measles-Mumps-Rubella and Varicella Vaccinations and Multiple Sclerosis Activity

Clinical implications of natalizumab Fab-arm exchange in patients with multiple sclerosis

Epstein-Barr Virus-Associated Multiple Sclerosis: Recent Mechanistic Advances and Clinical Therapeutic Perspectives